NAFTA 2.0 Drug Provisions Pose Potential Obstacle for Passage

January 30, 2019

The U.S.-Mexico-Canada Agreement would reduce access to affordable medicines, the chairman of the Ways and Means Trade Subcommittee said.

Related Stories